SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

The decline in XRP is driven by the U.S. Senate's failure to advance the Crypto Clarity Act, which traders view as a major setback for short-term regulatory progress. While many express frustration and blame political deadlock for the market volatility, others remain optimistic about the asset's long-term utility and view the price drop as a buying opportunity.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending as the community anticipates upcoming clinical data for its lung cancer program and maintains bullish sentiment regarding the company's platform, commercial momentum, and path to profitability. While some participants expressed impatience for specific financial guidance, the overall discussion remains focused on the potential for institutional accumulation and the long-term value of the company's oncology pipeline.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is receiving attention primarily due to recent open-market insider purchases by the CEO, which traders are debating as either a signal of genuine high-conviction in the company's future or a symbolic gesture to bolster sentiment. Meanwhile, the community is closely tracking the brand's competitive position and recent marketing initiatives, such as its new sponsorship of ESPN's College GameDay.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

The conversation is dominated by frustration regarding the stock's recent downward price trend and volatility, with participants debating whether current levels present an accumulation opportunity or indicate further decline. Traders are specifically focused on the impact of the LivePerson acquisition, speculation about potential short squeezes, and reactions to the appointment of a new CFO.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is facing persistent downward pressure as investors weigh macroeconomic headwinds, including high interest rates, inflationary concerns, and geopolitical instability, against a long-term thesis centered on CEO Brad Jacobs' M&A strategy. While some investors remain optimistic about the company's long-term growth potential and recent executive appointments, others express frustration over continued share price depreciation, concerns regarding dilution, and the lack of a near-term catalyst.

Swarmer, Inc. is an AI-driven software company, which develops software platforms and AI systems for autonomous swarm control of drones and unmanned vehicles. The firm offers STYX AI Command and Control System, MINAS Autonomy and Collaboration AI, and TRIDENT Embedded Drone Operating System. The company was founded by Alex Fink and Serhii Kuprienko in May 2023 and is headquartered in Austin, TX.

Swarmer Inc.

Swarmer Inc. is trending significantly lower as investors react to the expiration of its post-IPO insider lock-up period, which has increased the potential selling supply. While some traders view the decline as an opportunity to initiate or add to positions given the company's drone-related growth prospects, others remain cautious about the firm's path to profitability and potential for further dilution.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

The community is debating the failure of the Digital Asset Market CLARITY Act to pass a Senate procedural vote, with many traders viewing the event as a catalyst for increased volatility and potential downside. While some investors interpret the legislative deadlock as a bearish signal for the broader crypto market, others maintain that Bitcoin's long-term utility and global adoption remain intact independent of U.S. regulatory outcomes.

Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics shares are experiencing volatility as traders react to positive final Phase 3 clinical data for its IgA nephropathy treatment, Trutakna, which demonstrated significant reductions in kidney disease progression. While the community is largely bullish, citing the data as best-in-class and expressing excitement for the upcoming FDA filing, some traders noted price weakness and attributed it to broader biotech sector headwinds and short-selling activity.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing significant volatility as traders debate whether current price fluctuations are driven by manipulative market games or concerns over regulatory and margin headwinds. While many investors are holding for a long-term recovery to previous highs, sentiment remains divided between those viewing the stock as an undervalued defensive play and others citing ongoing skepticism regarding management and industry-wide regulatory risks.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals is trending following positive top-line Phase 3 results for plozasiran in treating severe hypertriglyceridemia, with the community highlighting deep, durable triglyceride reductions and a significant decrease in acute pancreatitis events. While many traders are bullish on the company's RNAi platform and potential commercial outlook, others express frustration over intraday price volatility and what they perceive as institutional market manipulation.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Michael Burry Sells FLUT To Pile Into LULU Under $100 — Plus A New Bet On ZTS

Equity

Michael Burry says Lululemon’s valuation has become increasingly attractive and sees Zoetis as “very cheap” despite the risk of further downside.

Pfizer Stock Or Zoetis: Is The Comeback Worth Paying Up For?

Pfizer Stock Or Zoetis: Is The Comeback Worth Paying Up For...

Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Zoetis Inc. (NYSE:ZTS) today announced that Kristin Peck, Chief Executive Officer, and Jay Saccaro, EVP, Chief Financial Officer and Chief Operating Officer, will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14, 2026 at 1:50 p.m...

Michael Burry-Backed ZTS Stock Climbs Following FDA Green Light For Dog Pill Against Screwworm

The FDA authorized Zoetis’s Simparica TRIO—already sold since 2020 for heartworm, fleas and ticks—for treating New World screwworm in dogs and puppies.


Zoetis (ZTS) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Michael Burry Adds To NBIS, MU, ORCL Shorts — Says Nebius Is ‘What The Top Of A Boom Looks Like’

'The Big Short' investor is betting against AI-linked names even as he sees strong demand for compute as a potential warning sign for the sector.

Michael Burry Refreshes Bearish Palantir Trade Even As AI Rally Strains Short Bets 

Famed "Big Short" investor Michael Burry buys new out-of-the-money puts on Palantir and adds to his Zoetis stake.

Zoetis (ZTS) Looked Like a Winner. What Went Wrong?

Zoetis (ZTS) Looked Like a Winner. What Went Wrong...

Zoetis Q2 Earnings Call Highlights

From Freddie Mac to Zoetis: Burry’s Five Buys and Chip Short

Burry added to long positions in Freddie Mac, Mercado Libre, lululemon, Fiserv and Zoetis while shorting more SOXX and buying additional March 2027 puts.


Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.

Zoetis Inc - Ordinary Shares - Class A

Bearish Sentiment

50bps hike

25bps hike

No change

25bps cut

The Federal Reserve's September FOMC meeting concludes Wednesday, September 16, with a rate decision due at 2:00 PM ET, following Tuesday's CPI report that showed inflation still running above the Fed's 2% target. What do you think the Fed decides at this week's FOMC meeting? Vote and explain your reasoning in the comments.

The Fed&#39;s rate decision comes Wednesday at 2PM ET. What do you think happens?

Stocktwits

The Fed's rate decision comes Wednesday at 2PM ET. What do you think happens?

Feed

News

Sentiment

Earnings

Fundamentals

Info

ZTS News